For laboratory research use only - not for human consumption

Hub · Peptides in Perth: Research Guide, Delivery and WA Law

GHK-Cu in Perth

GHK-Cu is a small peptide joined to a copper ion. The peptide, GHK, is a chain of three amino acids: glycine, histidine and lysine. Papers from the 1970s describe it in human blood plasma. Our reading of the October 2026 Poisons Standard, F2026L01327, on 14 October 2026 records GHK-Cu as held. It states no status for GHK-Cu, in either direction.

Published 2026-11-06Updated 2026-11-06Written by Form Laboratories research team7 min read

Think of a tiny claw holding a coin. The claw is a chain of three amino acids. The coin is one copper ion. Together they make GHK-Cu. Researchers have studied this pair since the 1970s. A search for GHK-Cu in Perth then brings up four different kinds of record: papers, a law reading, a trial listing and catalogue paperwork. This page is part of the Perth research peptides hub, and it sits beside the main Perth research peptides page. It keeps each record apart so you can see what each one says and where it stops.

Catalogue listing: Buy GHK-Cu (research use only). This material is for laboratory research only.

Key facts

Key facts for GHK-Cu in Perth: Research Records and WA Status
Common nameGHK-Cu
PeptideGHK, glycine-histidine-lysine, joined to one copper(II) ion
CAS numbersFree peptide 49557-75-7; copper complex 89030-95-5
First reportsPeptide described in plasma in 1973; structure published in 1977 (Schlesinger et al., Experientia, 1977)
Poisons Standard readingHeld. No status stated for GHK-Cu, in either direction. Source: F2026L01327, read 14 October 2026
Registered trialNCT07437586, Phase 2, recruiting, no results posted, checked 14 October 2026
Store listing nameGHK-Cu (freeze-dried research reference)
Listing lot24-0417
Scan on fileHeavy metals analysis, lot FL20260410-GHK-50. The lot differs from the listing lot
Schlesinger et al., Experientia, 1977Pickart and Margolina, International Journal of Molecular Sciences, 2018Hureau et al., Chemistry, 2011

Which research subject does "GHK-Cu Perth" refer to?

GHK-Cu is the copper(II) complex of GHK, a peptide made of three amino acids. Copper(II) means copper with two positive charges. Schlesinger and colleagues (Experientia, 1977) reported its structure. So a search for GHK-Cu in Perth points first at a molecule with a research record. The GHK-Cu research guide tells the story in more depth than this page.

The name follows the parts. G, H and K stand for glycine, histidine and lysine. Cu is the symbol for copper. Pickart and Margolina (International Journal of Molecular Sciences, 2018) say the peptide was described in plasma in 1973. In solution, three nitrogen atoms in the peptide hold the copper (Hureau et al., Chemistry, 2011). The free peptide and the copper complex have separate CAS numbers. A CAS number is a registry number for one chemical. This page is about the copper complex. A paper about the molecule says nothing about any vial, any law or any lot. That is why the questions below come after this one.

Poisons Standard October 2026 instrument, F2026L01327ClinicalTrials.gov, NCT07437586Form Laboratories catalogue

Evidence limits

What can these GHK-Cu records leave unresolved?

GHK-Cu has four records, and each one answers a narrow question. The papers describe a molecule. The law reading records what one document said on one day. The trial listing shows a plan and a status. The catalogue paperwork names one scan and one test. No record can answer the question that belongs to another. So this page reads them one at a time.

Read the four records as separate documents. Each was written for its own purpose. A science paper cannot approve a supply. A law reading that states no status is not a statement of permission. A trial listing with no results shows no outcome. A scan for one lot cannot describe a different lot. Each of these sentences marks a limit. None is a new legal finding. The order matters too. You need the molecule before you read its law record. You need that record before you look at any material.

ClinicalTrials.gov, NCT07437586, checked 14 October 2026

What does the trial registry show for GHK-Cu?

ClinicalTrials.gov lists one registered Phase 2 trial of GHK-Cu, NCT07437586. It is randomised, double-blind and vehicle-controlled. A vehicle is the plain base that carries the test material. The trial uses split wounds, which means two small standard skin wounds on one person. On 14 October 2026 the listing showed the trial as recruiting, with the status last verified in February 2026 and no results posted.

A registry entry is a plan and a status. It is not a result. With no results posted, the trial shows no outcome for GHK-Cu or for any material. This page reports no finding from it. The listing may have changed since 14 October 2026, and we have not checked it since.

Schlesinger et al., Experientia, 1977Hureau et al., Chemistry, 2011Pickart and Margolina, International Journal of Molecular Sciences, 2018

What question does each GHK-Cu paper address?

Three papers support the research record on this page, and each answers a different kind of question. Schlesinger and colleagues (Experientia, 1977) reported the structure of the peptide. Hureau and colleagues (Chemistry, 2011) studied how the peptide holds copper in solution. Pickart and Margolina (International Journal of Molecular Sciences, 2018) wrote a review of the history. A paper about a molecule is not a test of any supplied lot.

Each paper measures something different, which is why they sit side by side. The 1977 paper is about structure. The 2011 paper is about chemistry in solution, where three nitrogen atoms hold the copper. The 2018 review is a summary, and its authors have long worked in this field. This page reports no result from any paper about a person. A paper can show how a lock is built. It cannot show which key has been cut for it.

Form Laboratories catalogue

What does the GHK-Cu material's paperwork actually record?

The store lists GHK-Cu as a freeze-dried powder in one size. The listing says the powder is a blue solid. It names storage at 2-8 C, protected from light, and lot 24-0417. A scan on file names a different lot, FL20260410-GHK-50, and one test: heavy metals analysis. Because the lots differ, this page does not read the scan as a report for the listed lot.

A report describes only the sample and the tests it names. A heavy metals test looks for metals. It is not a test of identity, and this page does not call it one. What a lot number can establish explains how a lot code points to one production run. This page has not independently opened a report for lot 24-0417. It makes no claim about release approval.

Form Laboratories shipping page

Which part of the Perth journey can a tracking record answer?

Tracking can record a parcel's progress and an estimated delivery date. It does not show identity, purity or legal permission. The store's shipping page says every order leaves Perth, Western Australia. It is packed and sent by Australia Post or CouriersPlease after payment has cleared. A tracking email follows when the order is packed and handed over. The dispatch and tracking record is the whole of what this page draws on for the journey.

The shipping page says the outer packaging is plain and unbranded. It gives no sign of the contents or the store. Certificates of Analysis are available on request. The route is domestic and online-only. There is no public counter or collection point. A route is not an answer to the legal question this page opened with. Perth enters here as the place a parcel starts. These notes describe the store at Form Laboratories in Perth. Nothing in them gives an address, opening hours or a place to visit.

Comparison

Four records, four questions. Each column is one record. Each row states what it is drawn from, the question it answers and the question it cannot answer. The table separates the records. It does not rank them or compare products.

Comparison: GHK-Cu in Perth: Research Records and WA Status
Record detailResearch papersPoisons Standard readingRegistered trialCatalogue paperwork
Drawn fromSchlesinger et al., Experientia, 1977; Hureau et al., Chemistry, 2011; Pickart and Margolina, 2018F2026L01327, as-made text, read 14 October 2026ClinicalTrials.gov, NCT07437586, checked 14 October 2026The catalogue listing (lot 24-0417) and a scan naming lot FL20260410-GHK-50
Question it answersWhat the molecule is and how it holds copperWhat our record says about GHK-Cu on one date: held, no status statedWhether a trial is registered and what its status was on one dateWhat the listing and the scan on file name
Question it cannot answerWhether any supply is approved, or what any vial containsWhether a particular sale is permitted, or whether a later edition differsAny outcome, because no results are postedWhat is in the listed lot, because the scan names a different lot

FAQ

What did the October 2026 Poisons Standard reading record for GHK-Cu?

Our reading of F2026L01327, the October 2026 Poisons Standard, records GHK-Cu as held. It states no status for GHK-Cu, in either direction. We read the as-made text on 14 October 2026 (UTC). It is not a statement of permission, and we have not checked a later edition.

Is there a registered trial of GHK-Cu?

ClinicalTrials.gov lists NCT07437586, a Phase 2 trial of GHK-Cu on small standard skin wounds. It is randomised, double-blind and vehicle-controlled. On 14 October 2026 it showed the trial as recruiting, with no results posted. A listing with no results shows no outcome.

Does the scan on file show what is in the listed GHK-Cu lot?

The scan on file does not show what is in the listed GHK-Cu lot. It names lot FL20260410-GHK-50 and one test, heavy metals analysis. The store listing names lot 24-0417. The lots differ, so this page does not read the scan as a report for the listed lot.

What does GHK-Cu stand for?

GHK-Cu names a peptide joined to copper. GHK stands for glycine, histidine and lysine, the three amino acids in the chain. Cu is the chemical symbol for copper. The copper is held as copper(II). Pickart and Margolina (International Journal of Molecular Sciences, 2018) say the peptide was described in plasma in 1973.

Citations

3 sources
  1. Schlesinger DH, Pickart L, Thaler MM. Experientia. 1977;33(3):324-325.
    doi:10.1007/BF02002806

  2. Hureau C et al. Chemistry. 2011;17(36):10151-10160.
    doi:10.1002/chem.201100751

  3. Pickart L, Margolina A. International Journal of Molecular Sciences. 2018;19(7):1987.
    doi:10.3390/ijms19071987

Written by

Form Laboratories research team

Perth, Western Australia. We supply research-use-only reference material.

Written in-house
These articles are written and maintained by our own research team, not by a named clinician.
Built from the record
Every figure comes from published literature, listed in full above with a link to the original paper.
No use directions
We describe what the research measured. We give no use directions, preparation steps or advice.

Form Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.

2026 Form Laboratories - Research use only - Perth WAPerth WA 6000 - dispatched Australia-wide via Australia Post or CouriersPlease